Abdominal Muscle Strengthening for Menstrual Symptoms in Primary Dysmenorrhea
STAMP
Effects of Abdominal Muscle Strengthening Using Stabilizer Pressure Biofeedback on Menstrual Symptoms and Abdominal Muscle Strength in Young Women With Primary Dysmenorrhea: A Randomized Controlled Trial
1 other identifier
interventional
58
0 countries
N/A
Brief Summary
This randomized controlled trial aims to investigate the effects of abdominal muscle strengthening exercises using a stabilizer pressure biofeedback device on menstrual symptoms and abdominal muscle strength in young women with primary dysmenorrhea. Primary dysmenorrhea, characterized by painful menstrual cramps without underlying pelvic pathology, is common among women of reproductive age and can negatively affect quality of life. In this study, 58 female participants aged 18-25 with regular menstrual cycles and a Visual Analog Scale (VAS) pain score of ≥4 will be randomly assigned to either an intervention group or a control group. The intervention group will perform abdominal strengthening and stretching exercises guided by a stabilizer pressure biofeedback device, three times per week for 6 weeks (excluding menstruation weeks). The main outcomes include menstrual symptom severity (assessed by the Menstrual Symptom Scale), pain intensity (VAS), and abdominal muscle strength (measured using the stabilizer pressure biofeedback device). The results will help determine whether targeted abdominal muscle training can reduce menstrual symptoms and improve muscle strength in women with primary dysmenorrhea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2025
CompletedStudy Start
First participant enrolled
August 13, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2025
CompletedAugust 19, 2025
August 1, 2025
1 month
August 12, 2025
August 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Menstrual Symptom Severity
Change in menstrual symptom severity as assessed by the Menstrual Symptom Scale (MSS). The MSS consists of 22 items scored on a 5-point Likert scale, with higher scores indicating more severe symptoms.
Change from Baseline (Week 0) to Post-intervention (Week 8)
Pain Intensity
Visual Analog Scale 0-10 cm (0 = no pain, 10 = worst pain). Outcome is mean change from baseline to Week 8.
Change from Baseline (Week 0) to Post-intervention (Week 8)
Abdominal Muscle Activation/Strength (Pressure Biofeedback)
Abdominal muscle activation measured with a Stabilizer Pressure Biofeedback Unit (mmHg). Lower pressure during correct drawing-in reflects better transversus abdominis activation. Outcome is change from baseline to Week 8
Change from Baseline (Week 0) to Post-intervention (Week 8)
Study Arms (2)
Intervention - Abdominal Muscle Strengthening with Stabilizer Pressure Biofeedback
EXPERIMENTALParticipants perform a structured exercise program targeting lumbar and abdominal muscles, guided by a stabilizer pressure biofeedback device. Sessions are supervised three times per week for 6 weeks (excluding menstruation weeks) and include mobility, stretching, and strengthening exercises to improve abdominal muscle activation and core stability.
Control - No Abdominal Muscle Strengthening Intervention
NO INTERVENTIONParticipants receive no abdominal muscle strengthening program during the study period. They continue their usual daily activities without any supervised exercise intervention.
Interventions
A supervised exercise program designed to strengthen abdominal and lumbar muscles, incorporating the use of a stabilizer pressure biofeedback device to enhance activation of deep stabilizing muscles such as the transversus abdominis. The program is delivered three times per week for 6 weeks (excluding menstruation weeks) and includes mobility, stretching, and strengthening exercises.
Eligibility Criteria
You may qualify if:
- Female participants aged 18-25 years
- Regular menstrual cycles
- Diagnosed with primary dysmenorrhea (no secondary dysmenorrhea or other gynecological disorders)
- Menstrual pain intensity ≥ 4 on the Visual Analog Scale (VAS) during the menstrual cycle
- Willingness to participate and ability to provide informed consent
You may not qualify if:
- Diagnosis of secondary dysmenorrhea or other gynecological disorders (e.g., endometriosis, adenomyosis, uterine fibroids)
- Current pregnancy or breastfeeding
- History of abdominal or pelvic surgery in the past 6 months
- Current use of hormonal therapy or analgesic medication that could affect menstrual pain assessment
- Participation in regular abdominal or core strengthening exercise programs within the last 3 months
- Any musculoskeletal, neurological, or systemic condition that could interfere with exercise performance or study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Assistant Professor of Physiotherapy
Zonguldak Bulent Ecevit University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- This study uses a single-blind design in which the outcomes assessor is unaware of participants' group allocation. Participants and care providers are aware of the assigned interventions, but the assessor responsible for data collection and outcome evaluation remains blinded throughout the trial to reduce measurement bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, PhD
Study Record Dates
First Submitted
August 12, 2025
First Posted
August 19, 2025
Study Start
August 13, 2025
Primary Completion
September 23, 2025
Study Completion
September 25, 2025
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because the study protocol and informed consent do not include provisions for public data sharing, and data protection regulations restrict the release of personally identifiable health information.